
Axolotl Biosciences
Co-Founder & CEO
LEADERSHIP PORTFOLIO
Dr. Stephanie Willerth is a professor, entrepreneur, consultant, and author, with research and innovation bridging academia and science.
FOUNDER - AXOLOTL BIOSCIENCES
As the Co-Founder and CEO of Axolotl Biosciences,
Dr. Willerth leads the charge in advancing the field of bioprinting. Specializing in the development of advanced bioinks,
Axolotl Biosciences equips researchers and healthcare professionals to create more accurate human tissue models for drug testing, disease modeling, & beyond. Under the leadership of Dr. Willerth and her co-founder, Axolotl is the only Canadian company to win the Falling Walls Venture Award.
CONSULTANT - STARFISH MEDICAL
As a consultant and bioservices advisor for StarFish Medical,
Dr. Willerth offers her expertise in neural tissue engineering and bioprinting to help guide the development of medical devices.
Her role bridges the gap between research and practical healthcare solutions, ensuring that new technologies are ethical, well-researched, & commercially viable.
AUTHOR
As the author of Engineering Neural Tissue from Stem Cells, Dr. Willerth has made her expertise in neural tissue engineering and bioprinting accessible to a broad audience. Her publications equip academics and industry leaders aiming to understand and apply the latest developments in biomedicine.

TESTIMONIALS
What They Say About Dr. Stephanie Willerth